PubRank

Bryan M Clary

Author PubWeight™ 90.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw 2009 3.25
2 Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007 2.62
3 Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 2007 2.26
4 Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011 2.13
5 A role for hepatic metastasectomy in stage IV melanoma and breast cancer: reestablishing the surgical modality. Oncology (Williston Park) 2011 2.04
6 Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer. Ann Surg Oncol 2005 1.88
7 Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 2008 1.83
8 Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 2006 1.70
9 The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Ann Surg Oncol 2012 1.66
10 Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy. Ann Surg Oncol 2006 1.62
11 Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations. Cancer Res 2011 1.58
12 Concomitant vascular reconstruction during pancreatectomy for malignant disease: a propensity score-adjusted, population-based trend analysis involving 10,206 patients. JAMA Surg 2013 1.58
13 Resident education in the era of patient safety: a nationwide analysis of outcomes and complications in resident-assisted oncologic surgery. Ann Surg Oncol 2013 1.52
14 Pancreatic duct strictures: identifying risk of malignancy. Ann Surg Oncol 2004 1.52
15 In vivo selection of tumor-targeting RNA motifs. Nat Chem Biol 2009 1.36
16 Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol 2011 1.31
17 Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 2005 1.28
18 Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth. Cancer Res 2007 1.27
19 Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. J Clin Oncol 2006 1.21
20 Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases. J Am Coll Surg 2007 1.19
21 The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer 2012 1.16
22 RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin. Mol Ther 2007 1.14
23 Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg 2012 1.14
24 A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg 2014 1.11
25 Examining reoperation and readmission after hepatic surgery. J Am Coll Surg 2013 1.10
26 Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. Int J Radiat Oncol Biol Phys 2007 1.10
27 Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis. J Am Coll Surg 2007 1.09
28 H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity. Nucleic Acids Res 2006 1.09
29 Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis. Ann Surg Oncol 2007 1.07
30 Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis. Biol Chem 2009 1.05
31 Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer. J Surg Res 2007 1.05
32 Major liver resection in elderly patients: a multi-institutional analysis. J Am Coll Surg 2011 1.05
33 A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. Ann Surg 2013 1.03
34 Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice. J Surg Res 2004 1.03
35 A standard definition of major hepatectomy: resection of four or more liver segments. HPB (Oxford) 2011 1.03
36 Workforce projections for hepato-pancreato-biliary surgery. J Am Coll Surg 2008 1.02
37 Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. Cancer 2011 1.02
38 Histological and molecular evaluation of patient-derived colorectal cancer explants. PLoS One 2012 1.01
39 Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? Ann Surg Oncol 2009 1.00
40 Targeted inhibition of alphavbeta3 integrin with an RNA aptamer impairs endothelial cell growth and survival. Biochem Biophys Res Commun 2005 1.00
41 Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer? J Surg Oncol 2012 1.00
42 Aptamer applications for targeted cancer therapy. Future Oncol 2010 1.00
43 Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis. Ann Surg Oncol 2008 0.99
44 Extended resection for pancreatic adenocarcinoma. Oncologist 2007 0.99
45 Surgical management of gallbladder cancer. Surg Oncol Clin N Am 2009 0.99
46 Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks? J Gastrointest Surg 2011 0.98
47 Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol 2007 0.97
48 Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer. J Am Geriatr Soc 2011 0.96
49 Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery 2013 0.96
50 Management of hepatic metastases from colorectal cancer. Clin Colon Rectal Surg 2005 0.93
51 Hepatobiliary cancers, version 2.2014. J Natl Compr Canc Netw 2014 0.93
52 Defining the learning curve for team-based laparoscopic pancreaticoduodenectomy. Ann Surg Oncol 2014 0.93
53 Liver transplantation for glycogen storage disease type Ia. J Hepatol 2009 0.92
54 Incidence of benign disease in patients that underwent resection for presumed pancreatic cancer diagnosed by endoscopic ultrasonography (EUS) and fine-needle aspiration (FNA). J Gastrointest Surg 2010 0.92
55 Regionalization of hepatic resections is associated with increasing disparities among some patient populations in use of high-volume providers. J Am Coll Surg 2008 0.91
56 Dual-phase 3D MDCT angiography for evaluation of the liver before hepatic resection. AJR Am J Roentgenol 2004 0.91
57 NF-kappaB inhibition by an adenovirus expressed aptamer sensitizes TNFalpha-induced apoptosis. Biochem Biophys Res Commun 2007 0.91
58 Hepatobiliary cancers. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2006 0.90
59 Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. J Gastrointest Surg 2014 0.88
60 Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. Ann Surg 2002 0.87
61 Pancreas-preserving duodenectomy in the management of duodenal familial adenomatous polyposis. J Gastrointest Surg 2002 0.86
62 Extended hepatic resection for gallbladder cancer. Am J Surg 2007 0.85
63 Pancreaticoduodenectomy: frequency and outcome of post-operative imaging-guided percutaneous drainage. Abdom Imaging 2009 0.84
64 Feeding jejunostomy tube placement in patients undergoing pancreaticoduodenectomy: an ongoing dilemma. J Gastrointest Surg 2014 0.83
65 Neuroendocrine liver metastases. Surg Clin North Am 2010 0.83
66 Vascular surgery collaboration during pancreaticoduodenectomy with vascular reconstruction. Ann Vasc Surg 2012 0.83
67 Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment. Curr Oncol Rep 2014 0.83
68 Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases. HPB (Oxford) 2009 0.82
69 Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram. Ann Surg Oncol 2006 0.82
70 Defining criteria for selective operative management of pancreatic cystic lesions: does size really matter? J Gastrointest Surg 2010 0.81
71 Hepatic parenchymal transection with vascular staplers: a comparative analysis with the crush-clamp technique. Am J Surg 2008 0.81
72 Venous thromboembolism after hepatic resection: analysis of 5,706 patients. J Gastrointest Surg 2012 0.81
73 Impact of simultaneous diaphragm resection during hepatectomy for treatment of metastatic colorectal cancer. J Gastrointest Surg 2012 0.80
74 A comparison of antiangiogenic therapies for the prevention of liver metastases. J Surg Res 2005 0.80
75 Trends in racial disparities in pancreatic cancer surgery. J Gastrointest Surg 2013 0.79
76 Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms. Ann Surg Oncol 2002 0.78
77 Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma. J Surg Oncol 2014 0.78
78 Is there a role for simultaneous hepatic and colorectal resections? A contemporary view from NSQIP. J Gastrointest Surg 2012 0.78
79 Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry. Ann Surg Oncol 2011 0.77
80 Does the presence of coronary artery disease impact perioperative outcomes following partial hepatectomy? J Gastrointest Surg 2014 0.77
81 Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study. J Gastrointest Surg 2008 0.76
82 Hepatic and pancreatic resection in patients with end-stage renal disease: a propensity analysis. HPB (Oxford) 2014 0.75
83 Wound classification reporting in HPB surgery: can a single word change public perception of institutional performance? HPB (Oxford) 2014 0.75
84 Simultaneous diaphragm and liver resection: a propensity-matched analysis of postoperative morbidity. J Am Coll Surg 2012 0.75
85 Venous Thromboembolism Prophylaxis in Liver Surgery. J Gastrointest Surg 2016 0.75
86 Hepatic tumor growth: target for angiogenesis inhibition? World J Surg 2005 0.75